Rich Pharmaceuticals, Inc.Company Review & Valuation

RCHA
OTC Markets
Latest Price
0.00USD
Market Capitalization
188.39kUSD

About Rich Pharmaceuticals, Inc.

Rich Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies in oncology. It is developing RP-323 for the treatment of Hodgkin's lymphoma, acute myelogenous leukemia, and to cause elevation of white blood cells. The company was formerly known as Nepia Show moreInc. and changed its name to Rich Pharmaceuticals, Inc., in August 2013. Rich Pharmaceuticals, Inc. was incorporated in 2010 and is based in Beverly Hills, California.Show less

Industry
Biotechnology
HQ Location
Beverly Hills, California

Stock Price

Price data not available for Rich Pharmaceuticals, Inc..

Performance

Please login or create a free account to view the contents of this section.

Similar Companies

KalVista Pharmaceuticals
Apricus Biosciences
Galapagos
Codexis

back to top